Acquired neutralizing breadth against SARS-CoV-2 variants including Omicron after three doses of mRNA COVID-19 vaccination and the vaccine efficacy

Koichi Furukawa, Lidya Handayani Tjan, Yukiya Kurahashi, Silvia Sutandhio, Mitsuhiro Nishimura, Jun Arii, Yasuko Mori
doi: https://doi.org/10.1101/2022.01.25.22269735

Article usage

Article usage: January 2022 to November 2024

AbstractFullPdf
Jan 202218054385
Feb 20221330149407
Mar 202232118123
Apr 20221722762
May 2022134647
Jun 20221231620
Jul 2022117713
Aug 202214527
Sep 202285214
Oct 202275215
Nov 202284012
Dec 20223006
Jan 20232115
Feb 20235226
Mar 20232823
Apr 20233615
May 20231814
Jun 20231452
Jul 20231014
Aug 2023211010
Sep 20231945
Oct 20231803
Nov 20232594
Dec 20232214
Jan 20241242
Feb 20242123
Mar 2024954
Apr 20241333
May 20242173
Jun 20241476
Jul 202415315
Aug 20241817
Sep 2024341114
Oct 202412116
Nov 20244315
Back to top
Posted January 25, 2022.
Download PDF
Data/Code
Email
Acquired neutralizing breadth against SARS-CoV-2 variants including Omicron after three doses of mRNA COVID-19 vaccination and the vaccine efficacy
Koichi Furukawa, Lidya Handayani Tjan, Yukiya Kurahashi, Silvia Sutandhio, Mitsuhiro Nishimura, Jun Arii, Yasuko Mori
medRxiv 2022.01.25.22269735; doi: https://doi.org/10.1101/2022.01.25.22269735
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area